Stool softener, fiber or laxative: which one for hemorrhoids?

For hemorrhoids, fiber has the trial evidence the other options do not. A meta-analysis of seven fiber trials, 378 patients, found that fiber cut the risk of symptoms that failed to improve by 47% (relative risk 0.53) and cut the risk of bleeding by 50% (relative risk 0.50) ¹. Stool softeners such as docusate are often handed out after a procedure or a birth. In the head-to-head trial that tested this directly, psyllium softened stool more than docusate ².

Osmotic laxatives and stimulant laxatives are constipation drugs. The 2023 AGA and ACG constipation guideline is the document that ranks them ³. This page separates bulk fiber, stool softeners, osmotic laxatives, and stimulants, then says which one to reach for when the problem is hemorrhoids. Product-by-product notes are on the best fiber supplements page and the best stool softeners page.

Bulk fiber

Bulk-forming fiber absorbs water and adds volume to stool. The supplements tested most often are psyllium and, less clearly, other fibers. NIDDK’s hemorrhoid treatment page lists a stool softener or a fiber supplement such as psyllium (Metamucil) or methylcellulose (Citrucel), plus high-fiber foods, fluids, and less straining, as home care ⁸.

The hemorrhoid meta-analysis is the one that matters for bleeding. Seven trials compared fiber with a non-fiber control. Studies were moderate quality. Besides the drops in persistent symptoms and bleeding, the pooled results for prolapse, pain, and itching were compatible with a benefit and also compatible with no effect, because the confidence intervals were wide. Follow-up was often at 6 weeks and at 3 months, and the benefit looked stable across those visits. One study suggested fewer recurrences. Mild side effects trended higher with fiber, and that trend was not statistically significant (relative risk 6.0, with a very wide confidence interval) ¹. So the reliable hemorrhoid result is fewer ongoing symptoms and less bleeding. The prolapse, pain, and itching results were too uncertain to call.

For constipation itself, a 2022 meta-analysis of fiber supplements pooled 16 randomized trials and 1,251 adults. Fiber responders were 311 of 473 people (66%), compared with 134 of 329 (41%) on control treatment (relative risk 1.48). Psyllium and pectin were the fibers with a significant effect. The response showed up at higher doses, over 10 grams a day. Stool frequency improved (standardized mean difference 0.72), and that frequency change showed up when the dose was high and the trial lasted at least 4 weeks. Stool consistency improved too, again mainly at higher doses. Flatulence was higher with fiber (standardized mean difference 0.80). The authors warned that the trials were heterogeneous, so the averages hide some noise ⁴.

The AGA/ACG panel suggests fiber supplements for chronic idiopathic constipation (conditional recommendation, low certainty). Their practical notes: check how much fiber is already in the diet, use a supplement first if intake is low, and among the fibers they evaluated only psyllium looks effective. Data on bran and inulin were very limited. Drink fluid with it. Gas is common. They also say a fiber trial can come before polyethylene glycol, or alongside it, for mild constipation ³.

How much food fiber is a separate number. NIDDK’s constipation treatment page, citing the Dietary Guidelines, says adults should get 22 to 34 grams of fiber a day, depending on age and sex, and should drink plenty of water and other liquids if they eat more fiber or take a supplement ⁵. A trial of 117 adults with functional constipation put everyone on about 25 grams of fiber a day for two months. One group drank fluids as they liked (mean 1.1 liters). The other was told to drink 2 liters of mineral water (mean intake 2.1 liters). Both groups had more frequent stools and used fewer laxatives. Both changes were larger in the higher-fluid group. The authors concluded that 25 grams of fiber helps, and that raising fluid toward 1.5 to 2.0 liters a day adds to the effect ⁶.

Food can stand in for a powder. A US trial partially randomized adults with chronic constipation to two green kiwifruit a day, 100 grams of prunes a day, or 12 grams of psyllium a day for 4 weeks. Complete data were available for 75 of 79 people. The share who gained at least one extra complete spontaneous bowel movement per week was similar for all three, and straining improved with all three. Side effects were most common with psyllium and least common with kiwifruit ⁷. Portion sizes are in the hemorrhoid diet.

Start lower than the full dose if you bloat easily, then move toward a supplemental dose above 10 grams a day if constipation is the target, and give it at least four weeks before you decide it failed ^3,4. The fiber calculator adds up a normal day so you can see the gap. Daily prevention habits around that number are in how to prevent hemorrhoids.

Stool softeners

A stool softener, in US pharmacies, almost always means docusate. NIDDK lists stool softeners (Colace, docusate) as one over-the-counter type a clinician may suggest for a short time, next to fiber supplements, osmotic agents, lubricants such as mineral oil, and stimulants ⁵.

The AGA/ACG panel included docusate in the list of surfactant and osmotic agents it looked for (alongside polyethylene glycol, magnesium oxide, and lactulose). Docusate is not among the 10 recommendations the panel issued. In the discussion, the authors noted a paucity of data for several very common treatments, and they named fiber, lactulose, senna, and docusate ³. Too few trials is why it missed the list.

The direct comparison is the McRorie trial of psyllium versus docusate. It was a randomized, double-blind study of 170 people with chronic idiopathic constipation: two weeks of placebo, then two weeks of treatment. One group took psyllium 5.1 grams twice a day. The other took docusate sodium 100 mg twice a day. Psyllium increased stool water content more (a rise of 2.33% versus 0.01% with docusate). Stool water weight was 84.0 grams per bowel movement with psyllium and 71.4 grams with docusate. Weekly stool output was 359.9 grams versus 271.9 grams. In treatment week 2, bowel movements averaged 3.5 per week with psyllium and 2.9 with docusate. Week 1 was not significantly different (3.3 versus 3.1). The authors’ conclusion was that psyllium is better at softening stool, by raising water content, and is the stronger laxative of the two ².

There is still a short-term role. A 2025 review of hemorrhoidal disease says that if you are seen more than 72 hours after an external hemorrhoid clots, medical treatment includes stool softeners and pain medicine such as 5% lidocaine ¹⁰. That is a few days of help while a clot settles, which is a different job from treating bleeding internal hemorrhoids for months. The clot timeline is in thrombosed hemorrhoid.

After excisional hemorrhoidectomy, the regimen in the best-known day-case trial was lactulose, an osmotic laxative, started two days before surgery and continued for two weeks, not a docusate softener ¹³. Recovery details are in the hemorrhoidectomy recovery timeline.

Capsules suit people who will not drink a powder. A dye-free docusate softener is the kind often sent home after birth or surgery, and a warehouse-club bottle is the same medicine. Buyers commonly describe softeners as gentle. Some report cramps. A full psyllium capsule dose is several capsules, and stomach discomfort often shows up when the water is skipped. Follow the label, and keep any softener course short unless your clinician says otherwise.

Osmotic laxatives

Osmotic laxatives keep water in the bowel so stool stays soft and moves. NIDDK’s examples are Milk of Magnesia and MiraLAX ⁵.

Polyethylene glycol (PEG, the ingredient in MiraLAX) is the one the AGA/ACG panel recommends, a strong recommendation with moderate certainty. They note that a response can last through 6 months. Side effects include abdominal distension, loose stool, flatulence, and nausea. For mild constipation they would still try fiber first, or use fiber with PEG ³.

A Cochrane review of lactulose versus polyethylene glycol included 10 randomized trials. PEG was better for stool frequency per week, stool form, relief of abdominal pain, and the need for extra products. That pattern held in adults and in children, except that the abdominal-pain advantage was not seen in the child subgroup. The authors said PEG should be preferred to lactulose ⁹.

Lactulose gets a conditional recommendation, very low certainty, for adults who fail or cannot tolerate over-the-counter therapy. Bloating and gas are common and get worse as the dose rises ³. It is what the St Mark’s hemorrhoidectomy trial gave everyone ¹³.

Magnesium oxide has a conditional recommendation with very low certainty. The trials ran about 4 weeks. The panel suggests starting at a lower dose and increasing if needed. Do not use it if your kidneys are impaired. Magnesium can build up and cause hypermagnesemia ³.

Stimulant laxatives

Stimulants nudge the bowel to contract. NIDDK’s examples include Dulcolax, and it says to use them only if constipation is severe or other treatments have not worked ⁵. A 2014 review found that both stimulant and nonstimulant laxatives beat placebo, with minor side effects in studies lasting from one week to one year. Only one of those studies compared the two groups head to head ¹¹.

The AGA/ACG panel splits the stimulants:

Bisacodyl or sodium picosulfate has a strong recommendation, moderate certainty, for short-term use or as rescue therapy. Short-term means daily use for 4 weeks or less. The panel said longer use is probably appropriate, though data on tolerance and side effects are still needed. The common side effects are abdominal pain, cramping, and diarrhea. Start at a lower dose and increase as you tolerate it ³.

Senna has a conditional recommendation, low certainty. The trials lasted 4 weeks. Doses in the trials were higher than the doses people usually take. Start lower and increase if nothing happens. Abdominal pain and cramping may show up at a higher dose ³.

Pregnancy

Constipation treatments in pregnancy have thin trial evidence. A Cochrane review could use only two studies and said that is not enough for a full verdict. Stimulant laxatives improved constipation more than bulk fiber (relative risk 1.59, 140 women) and caused more abdominal discomfort (relative risk 2.33) and more diarrhea (relative risk 4.50). Fiber raised stool frequency by a mean of 2.24 times per week versus no fiber (40 women). The review had no usable data on osmotic laxatives or stool softeners in pregnancy ¹². Check the choice with your obstetric clinician. Pregnancy-specific care is in hemorrhoids during pregnancy.

Which one to use for hemorrhoids

1. Start with food fiber plus a psyllium supplement if you are short of the 22 to 34 gram range, and drink fluid with it ^5,6. Give a dose above 10 grams of supplemental fiber about four weeks unless gas makes that impossible ⁴.
2. If stools are still hard, add or switch to polyethylene glycol. That is the over-the-counter drug with a strong recommendation ³.
3. Use bisacodyl or senna for rescue days. Daily use in the guideline is framed as four weeks or less unless a clinician agrees to longer. Expect cramps ^3,5.
4. Treat docusate as a short-term softener when you were given it after a clot, a birth, or a procedure. For bleeding hemorrhoids over the following weeks, the fiber trials are the stronger evidence ^1,2,10.
5. If you are still constipated after those steps, or you see bleeding that is new, heavy, dark, or paired with weight loss, fever, or a change in bowel habit, you need an exam. Screening for colorectal cancer is recommended from age 45 ¹⁴. What to do about the blood itself is in bleeding hemorrhoids, and the wider treatment path is in hemorrhoid treatment.

GuideToilet habits that help hemorrhoids

Toilet habits for hemorrhoids: less straining, shorter sits, a footstool, and gentle cleaning, based on the posture studies.

Fiber is the option with hemorrhoid trial data behind the bleeding result. When fiber is not enough for constipation, polyethylene glycol is the drug with the strong guideline recommendation ^1,3.